Med-Fine Capital
Overview
Med-Fine Capital is a Shanghai-based venture capital firm specializing in early-stage investments in the healthcare and life sciences sectors across China. The firm focuses on identifying and supporting high-potential companies developing breakthrough medical technologies, including biotechnology, medical devices, diagnostics, digital health, and healthcare services. Med-Fine Capital manages both RMB and USD-denominated funds, enabling it to support companies with both domestic and international growth paths. The firm's investment strategy emphasizes early-stage value discovery, targeting seed to late-stage opportunities with a focus on sectors such as oncology, autoimmune, metabolic, and central nervous system diseases. Med-Fine Capital aims to be a long-term strategic partner to its portfolio companies, providing not only capital but also strategic guidance and access to a global network of resources. The firm has invested in over 60 companies, including Mabworks, Eccogene, Zion, LYNK, Pharma Legacy, MagAssist, Alebund, Allorion, ImmVira, Degron, Allink, and Castalysis. Med-Fine Capital's leadership team combines deep industry knowledge with a strong global network and proven investment capabilities. The team is led by Managing Partner Jack Zhou and Dr. Vince Deng, Partner and Head of Biotech Investment. The firm's approach is grounded in deep scientific diligence and a long-term commitment to advancing patient outcomes, aiming to build a research-driven investment system rooted in clinical value and technological innovation, with global market value in mind and meeting unmet medical needs as the end game.
Investment Focus
- Early-stage healthcare and life sciences companies in China with innovative technologies and strong growth potential.
Portfolio Companies
Reach Med-Fine Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Med-Fine Capital
What sectors does Med-Fine Capital invest in?
Med-Fine Capital invests in Healthcare Services, Digital Health, Medical Devices, Diagnostics and Biotechnology, and is based in Shanghai, China. Med-Fine Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Med-Fine Capital invest at?
Med-Fine Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Med-Fine Capital invest in?
Med-Fine Capital invests across China.
Who are the partners at Med-Fine Capital?
Team members listed for Med-Fine Capital include Jingjing Chen (Investor Relations Director, Chief Esg Officer) and Yang Bai (Partner).
What companies has Med-Fine Capital invested in?
Med-Fine Capital's portfolio includes Immvira, Lynk, Eccogene, Mabworks, Zion, Pharma Legacy, MagAssist and Alebund.
How do I contact Med-Fine Capital?
Med-Fine Capital's contact details are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
